Masimo Corporation (NASDAQ:MASI) Short Interest Up 21.2% in March

Masimo Corporation (NASDAQ:MASI) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totaling 3,248,048 shares, a growth of 21.2% from the March 15th total of 2,680,885 shares. Approximately 6.7% of the company’s stock are sold short. Based on an average daily trading volume, of 1,934,658 shares, the days-to-cover ratio is presently 1.7 days.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Global Retirement Partners LLC purchased a new stake in shares of Masimo in the fourth quarter worth approximately $27,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of Masimo in the fourth quarter worth approximately $28,000. Los Angeles Capital Management LLC purchased a new stake in shares of Masimo in the fourth quarter worth approximately $31,000. Rothschild Investment LLC raised its stake in shares of Masimo by 12,950.0% in the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after purchasing an additional 259 shares during the last quarter. Finally, Torren Management LLC purchased a new stake in shares of Masimo in the fourth quarter worth approximately $35,000. 85.96% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on MASI shares. Stifel Nicolaus set a $180.00 price target on shares of Masimo in a research note on Tuesday, February 17th. BTIG Research lowered shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Wolfe Research lowered shares of Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Piper Sandler lowered shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target on the stock. in a report on Tuesday, February 17th. Finally, Raymond James Financial downgraded shares of Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Eight equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Reduce” and an average target price of $181.17.

Masimo Stock Up 0.1%

MASI opened at $178.39 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49. The business has a 50 day moving average price of $171.53 and a 200 day moving average price of $151.97. The firm has a market cap of $9.58 billion, a P/E ratio of -16.93, a price-to-earnings-growth ratio of 1.81 and a beta of 1.20. Masimo has a twelve month low of $125.94 and a twelve month high of $179.00.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.